Search results
Alzheimer's: Could a new approach halt or slow down progression?
Medical News Today· 4 days agoAbout 32 million people globally have Alzheimer’s disease. Researchers continue to look for a way to...
Grand Rapids hospital offering new treatment for Alzheimer's Disease
WZZM 13 Grand Rapids· 2 days agoTrinity Health Grand Rapids says it's the first in West Michigan to offer a lecanemab, a treatment...
Opinion: Early detection critical for Alzheimer’s and dementia
The Gazette· 1 day agoJune is Alzheimer’s and Brain Awareness Month, and the Alzheimer’s Association is encouraging...
Falling behind on bills may be early sign of dementia: Study
WDHN Dothan via Yahoo News· 3 days agoTreatment depends on the cause, says the CDC. “Neurodegenerative dementias, like Alzheimer’s...
Nutrition and fasting for the brain: Why the keto diet shows promise
Medical Xpress· 2 days agoThe turnout of more than 700 attendees, both live and online, at Eline Dekeyster's lecture on...
Guest column: With FDA approval of software treatment for depression, the digital medicine...
WRAL TechWire· 6 days agoIn a watershed moment for digital health innovation, the FDA recently granted clearance to Rejoyn, a...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 3 days agoThe FDA approves some new medical treatments quickly, before confirmatory trials are carried out, to...
Namenda Cost 2024: Coupons and More
Healthline· 2 days agoNamenda (memantine hydrochloride) is a prescription drug used to treat moderate to severe Alzheimer’s disease. Namenda’s cost may depend on factors, including ...
Grey’s Anatomy Season-Finale Recap: Burning Down the House
Vulture· 6 days agoOh, buddy, if Catherine Fox looked at me that way I’d be Googling how does a person join WITSEC?...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
The Woonsocket Call· 5 days agoEli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in patients with KRAS G12C-mutant advanced solid tumors ...